Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 7580731, 10 pages
http://dx.doi.org/10.1155/2016/7580731
Research Article

Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury

1Department of Pharmacology, Cardiovascular Research Laboratory, All India Institute of Medical Sciences, New Delhi 110029, India
2Department of Pharmacology, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 425405, India
3Department of Biomedical Science, Bhaskaracharya College of Applied Science, University of Delhi, Delhi 110075, India
4Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE

Received 18 January 2016; Accepted 16 February 2016

Academic Editor: Kota V. Ramana

Copyright © 2016 Kapil Suchal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kapil Suchal, Salma Malik, Nanda Gamad, et al., “Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7580731, 10 pages, 2016. https://doi.org/10.1155/2016/7580731.